公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2002 | Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Anti-Cancer Drugs | 57 | 48 | |
2000 | Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; CHANG-YAO HSIEH ; YEONG-SHIAU PU | Anticancer Research | 45 | 40 | |
2004 | Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide | Hour T.-C.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU | Anti-Cancer Drugs | 24 | 23 | |
2001 | Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells | YEONG-SHIAU PU ; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; Hour T.-C. | Journal of Urology | 20 | 18 | |
2002 | Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; YEONG-SHIAU PU | Prostate | 125 | 110 | |
2002 | Cytotoxicity of arsenic trioxide to transitional carcinoma cells | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Urology | 25 | 32 | |
2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | YEONG-SHIAU PU ; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Guan J.-Y.; Lin S.-R.; Hour T.-C. | Biochemical Pharmacology | 38 | 35 | |
1998 | Megestrol acetate antagonizes cisplatin cytotoxicity | YEONG-SHIAU PU ; ANN-LII CHENG ; Chen J.; Guan J.-Y.; Lu S.-H.; Lai M.-K.; CHANG-YAO HSIEH | Anti-Cancer Drugs | 3 | 3 |